Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Latiglutenase as a Treatment for Celiac Disease
- First Posted Date
- 2018-07-13
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- Immunogenics, LLC
- Target Recruit Count
- 79
- Registration Number
- NCT03585478
- Locations
- 🇺🇸
Mayo Clinic - 200 First Street SW, Rochester, Minnesota, United States
News
No news found